시장조사 보고서 : 세계의 항비만약 시장예측 2021년-2026년

■ 영문 제목 : Global Anti Obesity Drugs Market Growth 2021-2026
	■ 상품코드 : LPI-2108K200019 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 164 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (경구약, 다이어트 패치, 기타)와 용도별 시장규모 (남성용, 여성용) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 항비만약 시장 점유율
- 지역별 항비만약 시장규모
- 주요지역의 종류별 시장규모 (경구약, 다이어트 패치, 기타)
- 주요지역의 용도별 시장규모 (남성용, 여성용)
- 미주의 항비만약 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 항비만약 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 항비만약 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 항비만약 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 항비만약 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Obesity Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti Obesity Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral Medicine
Diet Patch
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Men
Women

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Merck
Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti Obesity Drugs Consumption 2016-2026
2.1.2 Anti Obesity Drugs Consumption CAGR by Region
2.2 Anti Obesity Drugs Segment by Type
2.2.1 Oral Medicine
2.2.2 Diet Patch
2.2.3 Other
2.3 Anti Obesity Drugs Sales by Type
2.3.1 Global Anti Obesity Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Anti Obesity Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti Obesity Drugs Sale Price by Type (2016-2021)
2.4 Anti Obesity Drugs Segment by Application
2.4.1 Men
2.4.2 Women
2.5 Anti Obesity Drugs Sales by Application
2.5.1 Global Anti Obesity Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Anti Obesity Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti Obesity Drugs Sale Price by Application (2016-2021)

3 Global Anti Obesity Drugs by Company
3.1 Global Anti Obesity Drugs Sales Market Share by Company
3.1.1 Global Anti Obesity Drugs Sales by Company (2019-2021)
3.1.2 Global Anti Obesity Drugs Sales Market Share by Company (2019-2021)
3.2 Global Anti Obesity Drugs Revenue Market Share by Company
3.2.1 Global Anti Obesity Drugs Revenue by Company (2019-2021)
3.2.2 Global Anti Obesity Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Anti Obesity Drugs Sale Price by Company
3.4 Global Manufacturers Anti Obesity Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti Obesity Drugs Product Location Distribution
3.4.2 Players Anti Obesity Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti Obesity Drugs by Region
4.1 Global Anti Obesity Drugs by Region
4.1.1 Global Anti Obesity Drugs Sales by Region
4.1.2 Global Anti Obesity Drugs Revenue by Region
4.2 Americas Anti Obesity Drugs Sales Growth
4.3 APAC Anti Obesity Drugs Sales Growth
4.4 Europe Anti Obesity Drugs Sales Growth
4.5 Middle East & Africa Anti Obesity Drugs Sales Growth

5 Americas
5.1 Americas Anti Obesity Drugs Sales by Country
5.1.1 Americas Anti Obesity Drugs Sales by Country (2016-2021)
5.1.2 Americas Anti Obesity Drugs Revenue by Country (2016-2021)
5.2 Americas Anti Obesity Drugs Sales by Type
5.3 Americas Anti Obesity Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti Obesity Drugs Sales by Region
6.1.1 APAC Anti Obesity Drugs Sales by Region (2016-2021)
6.1.2 APAC Anti Obesity Drugs Revenue by Region (2016-2021)
6.2 APAC Anti Obesity Drugs Sales by Type
6.3 APAC Anti Obesity Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti Obesity Drugs by Country
7.1.1 Europe Anti Obesity Drugs Sales by Country (2016-2021)
7.1.2 Europe Anti Obesity Drugs Revenue by Country (2016-2021)
7.2 Europe Anti Obesity Drugs Sales by Type
7.3 Europe Anti Obesity Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti Obesity Drugs by Country
8.1.1 Middle East & Africa Anti Obesity Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti Obesity Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti Obesity Drugs Sales by Type
8.3 Middle East & Africa Anti Obesity Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti Obesity Drugs Distributors
10.3 Anti Obesity Drugs Customer

11 Global Anti Obesity Drugs Market Forecast
11.1 Global Anti Obesity Drugs Forecast by Region
11.1.1 Global Anti Obesity Drugs Forecast by Regions (2021-2026)
11.2.2 Global Anti Obesity Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti Obesity Drugs Forecast by Type
11.7 Global Anti Obesity Drugs Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Pfizer Company Information
12.1.2 Pfizer Anti Obesity Drugs Product Offered
12.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Anti Obesity Drugs Product Offered
12.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Anti Obesity Drugs Product Offered
12.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roche Main Business Overview
12.3.5 Roche Latest Developments
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Information
12.4.2 GlaxoSmithKline Anti Obesity Drugs Product Offered
12.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 GlaxoSmithKline Main Business Overview
12.4.5 GlaxoSmithKline Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Anti Obesity Drugs Product Offered
12.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Anti Obesity Drugs Product Offered
12.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Boehringer Ingelheim Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Information
12.7.2 Novo Nordisk Anti Obesity Drugs Product Offered
12.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novo Nordisk Main Business Overview
12.7.5 Novo Nordisk Latest Developments
12.8 Eisai
12.8.1 Eisai Company Information
12.8.2 Eisai Anti Obesity Drugs Product Offered
12.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Eisai Main Business Overview
12.8.5 Eisai Latest Developments
12.9 Norgine
12.9.1 Norgine Company Information
12.9.2 Norgine Anti Obesity Drugs Product Offered
12.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Norgine Main Business Overview
12.9.5 Norgine Latest Developments
12.10 Arena Pharmaceuticals
12.10.1 Arena Pharmaceuticals Company Information
12.10.2 Arena Pharmaceuticals Anti Obesity Drugs Product Offered
12.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Arena Pharmaceuticals Main Business Overview
12.10.5 Arena Pharmaceuticals Latest Developments
12.11 Orexigen Therapeutics
12.11.1 Orexigen Therapeutics Company Information
12.11.2 Orexigen Therapeutics Anti Obesity Drugs Product Offered
12.11.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Orexigen Therapeutics Main Business Overview
12.11.5 Orexigen Therapeutics Latest Developments
12.12 Vivus
12.12.1 Vivus Company Information
12.12.2 Vivus Anti Obesity Drugs Product Offered
12.12.3 Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Vivus Main Business Overview
12.12.5 Vivus Latest Developments
12.13 Alizyme
12.13.1 Alizyme Company Information
12.13.2 Alizyme Anti Obesity Drugs Product Offered
12.13.3 Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Alizyme Main Business Overview
12.13.5 Alizyme Latest Developments
12.14 Rhythm Pharmaceuticals
12.14.1 Rhythm Pharmaceuticals Company Information
12.14.2 Rhythm Pharmaceuticals Anti Obesity Drugs Product Offered
12.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Rhythm Pharmaceuticals Main Business Overview
12.14.5 Rhythm Pharmaceuticals Latest Developments
12.15 Shionogi
12.15.1 Shionogi Company Information
12.15.2 Shionogi Anti Obesity Drugs Product Offered
12.15.3 Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Shionogi Main Business Overview
12.15.5 Shionogi Latest Developments
12.16 Zafgan
12.16.1 Zafgan Company Information
12.16.2 Zafgan Anti Obesity Drugs Product Offered
12.16.3 Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Zafgan Main Business Overview
12.16.5 Zafgan Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti Obesity Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral Medicine
Table 3. Major Players of Diet Patch
Table 4. Major Players of Other
Table 5. Global Anti Obesity Drugs Sales by Type (2016-2021) & (K Units)
Table 6. Global Anti Obesity Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Anti Obesity Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Anti Obesity Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Anti Obesity Drugs Sale Price by Type (2016-2021)
Table 10. Global Anti Obesity Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Anti Obesity Drugs Value by Application (2016-2021)
Table 13. Global Anti Obesity Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Anti Obesity Drugs Sale Price by Application (2016-2021)
Table 15. Global Anti Obesity Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Anti Obesity Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Anti Obesity Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Anti Obesity Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Anti Obesity Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Anti Obesity Drugs Producing Area Distribution and Sales Area
Table 21. Players Anti Obesity Drugs Products Offered
Table 22. Anti Obesity Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti Obesity Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Anti Obesity Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Anti Obesity Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Anti Obesity Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Anti Obesity Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Anti Obesity Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Anti Obesity Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Anti Obesity Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Anti Obesity Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Anti Obesity Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Anti Obesity Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Anti Obesity Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Anti Obesity Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Anti Obesity Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Anti Obesity Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Anti Obesity Drugs Sales by Type (2016-2021) & (K Units)
Table 42. APAC Anti Obesity Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Anti Obesity Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Anti Obesity Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Anti Obesity Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Anti Obesity Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Anti Obesity Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Anti Obesity Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Anti Obesity Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Anti Obesity Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Anti Obesity Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Anti Obesity Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Anti Obesity Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Anti Obesity Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Anti Obesity Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Anti Obesity Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Anti Obesity Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Anti Obesity Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Anti Obesity Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Anti Obesity Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Anti Obesity Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Anti Obesity Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Anti Obesity Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Anti Obesity Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Pfizer Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Pfizer Anti Obesity Drugs Product Offered
Table 71. Pfizer Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. Merck Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Merck Anti Obesity Drugs Product Offered
Table 76. Merck Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Roche Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Anti Obesity Drugs Product Offered
Table 81. Roche Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. GlaxoSmithKline Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. GlaxoSmithKline Anti Obesity Drugs Product Offered
Table 86. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 87. GlaxoSmithKline Main Business
Table 88. GlaxoSmithKline Latest Developments
Table 89. AstraZeneca Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. AstraZeneca Anti Obesity Drugs Product Offered
Table 91. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 92. AstraZeneca Main Business
Table 93. AstraZeneca Latest Developments
Table 94. Boehringer Ingelheim Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Anti Obesity Drugs Product Offered
Table 96. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
Table 99. Novo Nordisk Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Novo Nordisk Anti Obesity Drugs Product Offered
Table 101. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 102. Novo Nordisk Main Business
Table 103. Novo Nordisk Latest Developments
Table 104. Eisai Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Eisai Anti Obesity Drugs Product Offered
Table 106. Eisai Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 107. Eisai Main Business
Table 108. Eisai Latest Developments
Table 109. Norgine Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Norgine Anti Obesity Drugs Product Offered
Table 111. Norgine Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 112. Norgine Main Business
Table 113. Norgine Latest Developments
Table 114. Arena Pharmaceuticals Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Arena Pharmaceuticals Anti Obesity Drugs Product Offered
Table 116. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 117. Arena Pharmaceuticals Main Business
Table 118. Arena Pharmaceuticals Latest Developments
Table 119. Orexigen Therapeutics Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Orexigen Therapeutics Anti Obesity Drugs Product Offered
Table 121. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 122. Orexigen Therapeutics Main Business
Table 123. Orexigen Therapeutics Latest Developments
Table 124. Vivus Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Vivus Anti Obesity Drugs Product Offered
Table 126. Vivus Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 127. Vivus Main Business
Table 128. Vivus Latest Developments
Table 129. Alizyme Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Alizyme Anti Obesity Drugs Product Offered
Table 131. Alizyme Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 132. Alizyme Main Business
Table 133. Alizyme Latest Developments
Table 134. Rhythm Pharmaceuticals Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Rhythm Pharmaceuticals Anti Obesity Drugs Product Offered
Table 136. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 137. Rhythm Pharmaceuticals Main Business
Table 138. Rhythm Pharmaceuticals Latest Developments
Table 139. Shionogi Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Shionogi Anti Obesity Drugs Product Offered
Table 141. Shionogi Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 142. Shionogi Main Business
Table 143. Shionogi Latest Developments
Table 144. Zafgan Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Zafgan Anti Obesity Drugs Product Offered
Table 146. Zafgan Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 147. Zafgan Main Business
Table 148. Zafgan Latest Developments
List of Figures
Figure 1. Picture of Anti Obesity Drugs
Figure 2. Anti Obesity Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti Obesity Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Anti Obesity Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti Obesity Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral Medicine
Figure 10. Product Picture of Diet Patch
Figure 11. Product Picture of Other
Figure 12. Global Anti Obesity Drugs Sales Market Share by Type in 2020
Figure 13. Global Anti Obesity Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Anti Obesity Drugs Consumed in Men
Figure 15. Global Anti Obesity Drugs Market: Men (2016-2021) & (K Units)
Figure 16. Anti Obesity Drugs Consumed in Women
Figure 17. Global Anti Obesity Drugs Market: Women (2016-2021) & (K Units)
Figure 18. Global Anti Obesity Drugs Sales Market Share by Application (2016-2021)
Figure 19. Global Anti Obesity Drugs Revenue Market Share by Application in 2020
Figure 20. Global Anti Obesity Drugs Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Anti Obesity Drugs Revenue Market Share by Company in 2020
Figure 22. Global Anti Obesity Drugs Sales Market Share by Regions (2016-2021)
Figure 23. Global Anti Obesity Drugs Revenue Market Share by Region in 2020
Figure 24. Americas Anti Obesity Drugs Sales 2016-2021 (K Units)
Figure 25. Americas Anti Obesity Drugs Revenue 2016-2021 ($ Millions)
Figure 26. APAC Anti Obesity Drugs Sales 2016-2021 (K Units)
Figure 27. APAC Anti Obesity Drugs Revenue 2016-2021 ($ Millions)
Figure 28. Europe Anti Obesity Drugs Sales 2016-2021 (K Units)
Figure 29. Europe Anti Obesity Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Anti Obesity Drugs Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Anti Obesity Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Americas Anti Obesity Drugs Sales Market Share by Country in 2020
Figure 33. Americas Anti Obesity Drugs Revenue Market Share by Country in 2020
Figure 34. Americas Anti Obesity Drugs Sales Market Share by Type in 2020
Figure 35. Americas Anti Obesity Drugs Sales Market Share by Application in 2020
Figure 36. United States Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Anti Obesity Drugs Sales Market Share by Region in 2020
Figure 41. APAC Anti Obesity Drugs Revenue Market Share by Regions in 2020
Figure 42. APAC Anti Obesity Drugs Sales Market Share by Type in 2020
Figure 43. APAC Anti Obesity Drugs Sales Market Share by Application in 2020
Figure 44. China Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Anti Obesity Drugs Sales Market Share by Country in 2020
Figure 51. Europe Anti Obesity Drugs Revenue Market Share by Country in 2020
Figure 52. Europe Anti Obesity Drugs Sales Market Share by Type in 2020
Figure 53. Europe Anti Obesity Drugs Sales Market Share by Application in 2020
Figure 54. Germany Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Anti Obesity Drugs Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Anti Obesity Drugs Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Anti Obesity Drugs Sales Market Share by Application in 2020
Figure 63. Egypt Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Anti Obesity Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles

※본 조사보고서 [세계의 항비만약 시장예측 2021년-2026년] (코드 : LPI-2108K200019) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 항비만약 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 동물용 통증 관리약 시장예측 2021년-2026년
LPI-2108K201967 / LP Information / 2021년 8월 / 본 조사보고서는 동물용 통증 관리약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 정신 장애 치료약 시장예측 2021년-2026년
LPI-2108K201578 / LP Information / 2021년 8월 / 본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 양극성 장애 약물 시장예측 2021년-2026년
LPI-2108K202119 / LP Information / 2021년 8월 / 본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 입술 포진용 치료약 시장예측 2021년-2026년
LPI-2108K200023 / LP Information / 2021년 8월 / 본 조사보고서는 입술 포진용 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항우울제 시장예측 2021년-2026년
LPI-2108K202103 / LP Information / 2021년 8월 / 본 조사보고서는 항우울제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Antidepressant Drugs will have significant change from previous year. By the most conservative estimates of global Antidepressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12180 million in 2019. Over...

세계의 생물학적 치료제 시장예측 2021년-2026년
LPI-2108K202118 / LP Information / 2021년 8월 / 본 조사보고서는 생물학적 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in...

세계의 고지혈증 처방약 시장예측 2021년-2026년
LPI-2108K201466 / LP Information / 2021년 8월 / 본 조사보고서는 고지혈증 처방약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 감량 치료제 시장예측 2021년-2026년
LPI-2108K200004 / LP Information / 2021년 8월 / 본 조사보고서는 감량 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...